Trial Profile
Clinical Trials Insight: 700008811
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 24 Nov 2005
Price :
$35
*
At a glance
- Drugs Nesbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 24 Nov 2005 New trial record.